Lee Cheng-Han, Espinosa Inigo, Vrijaldenhoven Suzan, Subramanian Subbaya, Montgomery Kelli D, Zhu Shirley, Marinelli Robert J, Peterse Johannes L, Poulin Neal, Nielsen Torsten O, West Rob B, Gilks C Blake, van de Rijn Matt
Department of Pathology, Stanford University Medical Center, Stanford, California 94305, USA.
Clin Cancer Res. 2008 Mar 1;14(5):1423-30. doi: 10.1158/1078-0432.CCR-07-1712.
Macrophages are migratory cells that are frequently recruited to the site of tumors. Their presence is associated with poor clinical outcome in a variety of epithelial malignancies. The aim of this study is to examine the prognostic significance of tumor-associated macrophages in sarcomas.
Global gene expression profiling data of a series of soft tissue tumors were analyzed for macrophage-associated gene expression. Immunohistochemistry on tissue microarrays containing leiomyosarcoma cases with known clinical outcome was used to verify the presence of macrophages and to examine the relationship between tumor-associated macrophages and clinical outcome.
Gene expression profiling revealed high-level expression of several macrophage-associated genes such as CD163 and CD68 in a subset of leiomyosarcomas, indicating the presence of variable numbers of tumor-infiltrating macrophages. This was confirmed by CD68 and CD163 immunostaining of a tissue microarray containing 149 primary leiomyosarcomas. Kaplan-Meier survival analysis showed that high density of tumor-infiltrating macrophages as identified by CD163 or CD68 staining is associated with a significantly worse disease-specific survival in nongynecologic leiomyosarcomas, whereas leiomyosarcomas arising from the gynecologic tract showed no significant association between macrophage infiltration and survival. The presence of tumor necrosis did not correlate significantly with outcome.
An increased density of CD163- or CD68-positive tumor-infiltrating macrophages is associated with poor outcome in nongynecologic leiomyosarcomas. This may help the clinical management of patients with leiomyosarcomas.
巨噬细胞是迁移性细胞,常被募集到肿瘤部位。它们的存在与多种上皮性恶性肿瘤的不良临床结局相关。本研究旨在探讨肿瘤相关巨噬细胞在肉瘤中的预后意义。
分析一系列软组织肿瘤的全基因表达谱数据,以检测与巨噬细胞相关的基因表达。对含有已知临床结局的平滑肌肉瘤病例的组织微阵列进行免疫组织化学分析,以验证巨噬细胞的存在,并研究肿瘤相关巨噬细胞与临床结局之间的关系。
基因表达谱显示,在一部分平滑肌肉瘤中,几种与巨噬细胞相关的基因如CD163和CD68呈高水平表达,表明存在数量不等的肿瘤浸润巨噬细胞。这通过对包含149例原发性平滑肌肉瘤的组织微阵列进行CD68和CD163免疫染色得到证实。Kaplan-Meier生存分析表明,经CD163或CD68染色确定的高密度肿瘤浸润巨噬细胞与非妇科平滑肌肉瘤中显著更差的疾病特异性生存相关,而源自生殖道的平滑肌肉瘤中巨噬细胞浸润与生存之间无显著关联。肿瘤坏死的存在与结局无显著相关性。
CD163或CD68阳性肿瘤浸润巨噬细胞密度增加与非妇科平滑肌肉瘤的不良结局相关。这可能有助于平滑肌肉瘤患者的临床管理。